Omixon Biocomputing
Latest round
- Series C
Last raised
- Jan 2017
Total raised
- $1.7M
Investors
- 2
About Omixon Biocomputing
Omixon Biocomputing Ltd.Founded in 2011 and headquartered in Budapest, Hungary, Omixon Biocomputing Ltd. specializes in molecular diagnostics.Omixon Biocomputing Ltd. specializes in molecular diagnostics with a focus on HLA (Human Leukocyte Antigen) genotyping through Next Generation Sequencing (NGS) technologies. Their core product offerings include the Holotype HLA™, an NGS Assay and Software product designed for clinical use on Illumina® sequencers, and the NanoTYPE MONO™ & MONOall™ kits, which are tailored for single locus testing. Additionally, the HoloGRAFT ONE™ test is utilized in research applications to quantify donor-derived cell-free DNA in transplant recipients. These products cater primarily to histocompatibility laboratories and medical institutions, with a customer base that includes transplant centers and research facilities across North America, Europe, and select regions in Asia.Omixon's revenue model is structured around the sale of specialized products and services, primarily targeting B2B transactions with healthcare providers and research institutions. Their offerings include the flagship Holotype HLA™ and the NanoTYPE kits, which are available in various formats to meet specific needs. Customers engage in direct purchases, with products offered as Research Use Only (RUO) kits and clinical diagnostic solutions.Omixon Biocomputing Ltd. is focusing on the development of new products aimed at enhancing their diagnostic offerings, with details on specific launch dates to be announced. The company plans to expand into new markets, specifically targeting regions in Asia and North America by 2025.000 mn will be utilized to support these initiatives, including product development and market expansion strategies.
Who invested in Omixon Biocomputing
2 investors across 3 rounds
See all investors in Omixon Biocomputing
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Omixon Biocomputing
Who invested in Omixon Biocomputing?
Omixon Biocomputing has 2 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Omixon Biocomputing raised?
Omixon Biocomputing has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Omixon Biocomputing last raise money?
Omixon Biocomputing's most recent round on record is a Series C, in Jan 2017.
What does Omixon Biocomputing do?
Omixon Biocomputing is a software company.
Where is Omixon Biocomputing headquartered?
Omixon Biocomputing is headquartered in Budapest, Hungary.
Which VCs invest in companies like Omixon Biocomputing?
Among active investors with capital left to deploy, Index Ventures, European Investment Bank, Highland Europe and Marktlink Capital back software companies at Omixon Biocomputing's stage. Their profiles are linked below.
VCs backing software startups at Series C
Raising like Omixon Biocomputing? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.